Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-04T17:25:20.722Z Has data issue: false hasContentIssue false

Chapter 22 - Prevention of Intracerebral and Subarachnoid Haemorrhage

from Part V - Prevention

Published online by Cambridge University Press:  15 December 2020

Jeffrey L. Saver
Affiliation:
David Geffen School of Medicine, University of Ca
Graeme J. Hankey
Affiliation:
University of Western Australia, Perth
Get access

Summary

Intracerebral haemorrhage and subarachnoid haemorrhage are associated with considerable morbidity and mortality. Too often the focus is on acute treatment after a haemorrhage has occurred, instead of primary and secondary prevention. Medical therapies to control hypertension, achieve tobacco abstinence, and avoid excessive alcohol consumption can confer broad reductions in haemorrhage risk across pathophysiological subtypes. Judicious restriction of antiplatelet and anticoagulant therapies to only those individuals and those intensities for which they are indicated also can substantially reduce haemorrhagic stroke frequency. Specific endovascular and surgical therapies, judiciously employed, will further reduce risk of first or recurrent haemorrhage from structural vascular anomalies, including arteriovenous malformation, cavernous malformations, and saccular aneurysms. For unruptured intracranial aneurysms, features that favour consideration of preventive occlusion include include younger patient age, prior subarachnoid haemorrhage from a different aneurysm, familial intracranial aneurysms, large aneurysm size, irregular shape, basilar or vertebral artery location, and aneurysm growth on serial imaging. Among individuals who are technical candidates for either coiling or clipping, endovascular coiling is associated with a reduction in procedural morbidity and mortality but has a higher risk of recurrence.

Type
Chapter
Information
Stroke Prevention and Treatment
An Evidence-based Approach
, pp. 463 - 484
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akers, A, Al-Shahi Salman, R A, Awad, I, Dahlem, K, Flemming, K, Hart, B, et al. (2017). Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery, 80(5), 665–80.CrossRefGoogle ScholarPubMed
An, SJ, Kim, TJ, Yoon, B-W. (2017). Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke, 19(1), 310.CrossRefGoogle ScholarPubMed
Antithrombotic Trialists’ Collaboration, Baigent, C, Blackwell, L, Collins, R, Emberson, J, Godwin, J, Peto, R, et al. (2009). Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet, 373(9678), 1849–60.Google ScholarPubMed
Ariesen, MJ, Claus, SP, Rinkel, GJ, Algra, A. (2003). Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke, 34(8), 2060–5.Google Scholar
Aune, D, Giovannucci, E, Boffetta, P, Fadnes, LT, Keum, N, Norat, T, et al. (2017). Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality – a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol, 46(3), 1029–56.CrossRefGoogle ScholarPubMed
Backes, D, Vergouwen, MD, Tiel Groenestege, AT, Bor, AS, Velthuis, BK, Greving, JP, et al. (2015). PHASES score for prediction of intracranial aneurysm growth. Stroke, 46, 1221–6.Google Scholar
Backes, D, Rinkel, GJE, Greving, JP, Velthuis, BK, Murayama, Y, Takao, H, et al. (2017). ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysms. Neurology, 88(17), 1600–06.Google Scholar
Becske, T, Kallmes, DF, Saatci, I, McDougal, CG, Szikora, I, Lanzino, G, et al. (2013). Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology, 267(3), 858–68.Google Scholar
Bell, S, Daskalopoulou, M, Rapsomaniki, E, George, J, Britton, A, Bobak, M, et al. (2017). Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ, 356, j909.CrossRefGoogle ScholarPubMed
Biffi, A, Kuramatsu, JB, Leasure, A, Kamel, H, Kourkoulis, C, Schwab, K, et al. (2017). Oral anticoagulation and functional outcome after intracerebral hemorrhage. Ann Neurol, 82(5), 755–65.Google Scholar
Biffi, A, Sonni, A, Anderson, CD, Kissela, B, Jagiella, JM, Schmidt, H, et al.; International Stroke Genetics Consortium. (2010). Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol, 68(6), 934–43.CrossRefGoogle ScholarPubMed
Bor, AS, Koffijberg, H, Wermer, MJ, Rinkel, GJ. (2010). Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology, 74(21), 1671–9.Google Scholar
Boulanger, M, Poon, MT, Wild, SH, Al-Shahi Salman, R. (2016). Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage. Neurology, 87(9), 870–8.Google Scholar
Brinjikji, W, Zhu, Y-Q, Lanzino, B, Cloft, HJ, Murad, MH, Wang, Z, Kallmes, DF. (2016). Risk factors for growth of intracranial aneurysms: a systematic review and meta-analysis. AJNR, 37 (4), 615–20.CrossRefGoogle ScholarPubMed
Broderick, JP, Brown, RD Jr, Sauerbeck, L, Hornung, R, Huston, J III, Woo, D, et al. (2009). Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke, 40(6), 1952–7.Google Scholar
Brown, RD. (2010). Unruptured intracranial aneurysms. Semin Neurol, 30(5), 537–44.Google Scholar
Brown, RD Jr, Flemming, KD, Meyer, FB, Cloft, HJ, Pollock, BE, Link, MJ, et al. (2005). Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc, 80(2), 269–81.CrossRefGoogle ScholarPubMed
Brown, RD Jr, Huston, J, Hornung, R, Foroud, T, Kallmes, DF, Kleindorfer, D, et al. (2008). Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. J Neurosurg, 108(6), 1132–8.CrossRefGoogle ScholarPubMed
Bruins Slot, KM, Berge, E. (2018). Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. Cochrane Database Syst Rev, 3. doi:10.1002/14651858.CD008980.pub3.CrossRefGoogle ScholarPubMed
Can, A, Rudy, RF, Castro, VM, Yu, S, Dligach, D, Finan, S, et al. (2018). Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms: a case-control study. Neurology, 91(12), e1175e1181. doi:10.1212/WNL.0000000000006200.CrossRefGoogle ScholarPubMed
Chang, TR, Kowalski, RG, Caserta, F, Carhuapoma, JR, Tamargo, RJ, Naval, NS. (2013). Impact of acute cocaine use on aneurysmal subarachnoid hemorrhage. Stroke, 44(7), 1825–9.Google Scholar
Chou, R, Dana, T, Blazina, I, Daeges, M, Jeanne, TL. (2016). Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA, 316(19), 2008–24.Google Scholar
Darke, S, Lappin, J, Kaye, S, Duflou, J (2018). Clinical characteristics of fatal methamphetamine-related stroke: a national study. J Forensic Sci, 63(3), 735–9.Google Scholar
Darsaut, TE, Findlay, JM, Magro, E, Kotowski, M, Roy, D, Weill, A, et al. (2017). Surgical clipping or endovascular coiling for unruptured intracranial aneurysms: a pragmatic randomised trial. J Neurol Neurosurg Psychiatry, 88(8), 663–8.Google Scholar
Derdeyn, CP, Zipfel, GJ, Albuquerque, FC, Cooke, DL, Feldmann, E, Sheehan, JP, Torner, JC; American Heart Association Stroke Council. (2017). Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 48(8), e200e224.CrossRefGoogle ScholarPubMed
Ding, X, Liu, X, Tan, C, Yin, M, Wang, T, Liu, Y, et al. (2018). Resumption of antiplatelet therapy in patients with primary intracranial hemorrhage-benefits and risks: a meta-analysis of cohort studies. J Neurol Sci, 384, 133–8.Google Scholar
Etminan, N, Chang, HS, Hackenberg, K, de Rooij, NK, Vergouwen, MDI, Rinkel, GJE, Algra, A. (2019). Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol, 76(5), 588–97. doi:10.1001/jamaneurol.2019.0006. [Epub ahead of print]Google Scholar
Etminan, N, Brown, RD Jr, Beseoglu, K, Juvela, S, Raymond, J, Morita, A, et al. (2015). The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus. Neurology, 85(10), 881–9.Google Scholar
Ettehad, D, Emdin, CA, Kiran, A, Anderson, SG, Callender, T, Emberson, J, et al. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet, 387(10022), 957–67.Google Scholar
Feigin, V, Parag, V, Lawess, CMM, Rogers, A, Suh, II, Woodward, M, et al. (2005a). Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants. Stroke, 36(7), 1360–5.Google Scholar
Feigin, VL, Rinkel, GJ, Lawes, CM, Algra, A, Bennett, DA, van Gijn, J, et al. (2005b). Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke, 36(12)., 2773–80.Google Scholar
Feldmann, E, Broderick, JP, Kernan, WN, Viscoli, CM, Brass, LM, Brott, T, et al. (2005). Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke, 36(9), 1881–5.CrossRefGoogle Scholar
Flaherty, ML, Kissela, B, Woo, D, Kleindorfer, D, Alwell, K, Sekar, P, et al. (2007). The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology, 68(2), 116–21.Google Scholar
Flemming, KD, Graff-Radford, J, Aakre, J, Kantarci, K, Lanzino, G, et al. (2017). Population-based prevalence of cerebral cavernous malformations in older adults: Mayo Clinic Study of Aging. JAMA Neurol, 74, 801–05.Google Scholar
Greving, JP, Wermer, MJ, Brown, RD, Morita, A, Juvela, S, Yonekura, M, et al. (2014). Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol, 13(1), 5966.CrossRefGoogle ScholarPubMed
Guresir, E, Vatter, H, Schuss, P, Platz, J, Konczalla, J, de Rochement Rdu, M, et al. (2013). Natural history of small unruptured anterior circulation aneurysms: a prospective cohort study. Stroke, 44(11), 3027–31.Google Scholar
Hanger, HC, Wilkinson, TJ, Fayez-Iskander, N, Sainsbury, R. (2007). The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry, 78(8), 836–40.CrossRefGoogle ScholarPubMed
Hanif, H, Belley-Cote, EP, Alotaibi, A, Dvirnik, N, Neupane, B, Beyene, J, et al. (2018). Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino), 59(1), 128–39.Google ScholarPubMed
Hankey, GJ, Stevens, SR, Piccini, JP, Lokhnygina, Y, Mahaffey, KW, Halperin, JL, et al. ROCKET AF Steering Committee and Investigators. (2014). Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke, 45, 1304–12.Google Scholar
Hart, RG, Diener, HC, Yang, S, Connolly, SJ, Wallentin, L, Reilly, PA, et al. (2012). Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke, 43, 1511–17.Google Scholar
Hasan, DM, Mahaney, KB, Brown, RD, Meissner, I, Piepgras, DG, Huston, J, et al. (2011). Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke, 42(11), 3156–62.CrossRefGoogle ScholarPubMed
Hasan, DM, Chalouhi, N, Jabbour, P, Dumont, AS, Kung, DK, Magnotta, VA, et al. (2013). Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results. J Am Heart Assoc, 2(1), e000019. doi:10.1161/JAHA.112.000019.Google Scholar
Hemphill, JC 3rd, Greenberg, SM, Anderson, CS, Becker, K, Bendok, BR, Cushman, M, et al. (2015). Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 46(7), 2032–60.Google Scholar
Hitchcock, E, Gibson, WT. (2017). A review of the genetics of intracranial berry aneurysms and implications for genetic counseling. J Genet Couns, 26(1), 2131.Google Scholar
Horne, MA, Flemming, KD, Su, IC, Stapf, C, Jeon, JP, Li, D, et al.; Cerebral Cavernous Malformations Individual Patient Data Meta-analysis Collaborators. (2016). Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol, 15(2), 166–73.Google Scholar
Inohara, T, Xian, Y, Liang, L, Matsouaka, RA, Saver, JL, Smith, EE, et al. (2018). Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality. JAMA, 319(5), 463–73. doi:10.1001/jama.2017.21917.Google Scholar
International Study of Unruptured Intracranial Aneurysms Investigators. (1998). Unruptured intracranial aneurysms – risk of rupture and risks of surgical intervention. N Engl J Med, 339(24), 1725–33.Google Scholar
Kase, CS, Kurth, T. (2011). Prevention of intracerebral hemorrhage recurrence. Continuum (Minneap Minn), 17(6), 1304–17. doi:10.1212/01.CON.0000410037.64971.e3.Google Scholar
Kernan, WN, Viscoli, C. M., Brass, CM Broderick, LM Brott, JP Feldmann E, T, et al. (2000). Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med, 343(25), 1826–32.Google Scholar
Kim, H, Al-Shahi Salman, R, McCulloch, CE, Stapf, C, Young, WL; MARS Coinvestigators. (2014). Untreated brain arteriovenous malformation: patient level meta-analysis of hemorrhage predictors. Neurology, 83, 590–7.Google Scholar
Kleinloog, R, de Mul, N, Verweij, BH, Post, JA, Rinkel, GJE, Ruigrok, YM. (2018). Risk factors for intracranial aneurysm rupture: a systematic review. Neurosurgery, 82(4), 431–40.Google Scholar
Knopman, J, Stieg, PE. (2014). Management of unruptured brain arteriovenous malformations. Lancet, 383(9917), 581–3.CrossRefGoogle ScholarPubMed
Korja, M, Lehto, H, Juvela, S. (2014). Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish cohort study. Stroke, 45(7), 1958–63.Google ScholarPubMed
Kotowski, M, Naggara, O, Darsaut, TE, Nolet, S. (2013). Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011. J Neurol Neurosurg Psychiatry, 84(1), 42–8.Google Scholar
Krishnamurthi, RV, Moran, AE, Forouzanfar, MH, Bennett, DA, Mensah, GA, Lawes, CM, et al.; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group. (2014). The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study. Glob Heart, 9(1), 101–6.Google Scholar
Lappin, JM, Darke, S, Farrell, M. (2017). Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry, 88(12), 1079–91.CrossRefGoogle ScholarPubMed
Larsson, S C, Mannisto, S, Virtanen, MJ, Kontto, J, Albanes, D, Virtamo, J. (2008). Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke, 39(6), 1681–7.Google Scholar
Larsson, SC, Mannisto, S, Virtanen, MJ, Kontto, J, Albanes, D, Virtamo, J. (2009a). Dairy foods and risk of stroke. Epidemiology, 20(3), 355–60.Google Scholar
Larsson, SC, Mannisto, S, Virtanen, MJ, Kontto, J, Albanes, D, Virtamo, J. (2009b). Dietary fiber and fiber-rich food intake in relation to risk of stroke in male smokers. Eur J Clin Nutr, 63(8), 1016–24.Google Scholar
Larsson, SC, Wallin, A, Wolk, A, Markus, HS. (2016). Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med, 14(1), 178.Google Scholar
Lee, SM, Choi, NK, Lee, B-C, Cho, K-H, Yoon, B-W, Park, B-J. (2013). Caffeine-containing medicines increase the risk of hemorrhagic stroke. Stroke, 44(8), 2139–43.Google Scholar
Li, LM, Bulters, DO, Kirollos, R. (2012). A mathematical model of utility for single screening of asymptomatic unruptured intracranial aneurysms at the age of 50 years. Acta Neurochirurgica, 154(7), 1145–52.Google Scholar
Lloyd-Jones, DM, Hong, Y, Labarthe, D, Mozaffarian, D, Appel, LJ, Van Horn, L, et al., on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. (2010). Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation, 121, 586613.Google Scholar
Lopes, RD, Guimarães, PO, Kolls, BJ, Wojdyla, DM, Bushnell, CD, Hanna, M, et al. (2017). Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood, 129(22), 2980–7.CrossRefGoogle ScholarPubMed
McKinney, JS, Kostis, WJ. (2012). Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke, 43(8), 2149–56.Google Scholar
McNeil, JJ, Wolfe, R, Woods, RL, Tonkin, AM, Donnan, GA, Nelson, MR, et al.; ASPREE Investigator Group. (2018). Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med, 379(16), 15091518.Google Scholar
Mehan, WA Jr, Romero, JM, Hirsch, JA, Sabbag, DJ, Gonzalez, RG, Heit, JJ, et al. (2014). Unruptured intracranial aneurysms conservatively followed with serial CT angiography: could morphology and growth predict rupture? J Neurointerv Aurg, 6(10), 761–6.Google ScholarPubMed
Meschia, JF, Bushnell, C, Boden-Albala, B, Braun, LT, Bravata, DM, Chaturvedi, S, et al. (2014). Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45(12), 3754–832.Google Scholar
Mohr, JP, Parides, MK, Staph, C, Moquete, E, Moy, CS, Overbey, JR, et al. (2014). Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet, 383(9917), 614–21.Google Scholar
Morita, A, Kirino, T, Hashi, K, Aoki, N, Fukuhara, S, Hashimoto, N, et al. (2012). The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med, 366(26), 2474–82.Google Scholar
Morris, Z, Whiteley, WN, Longstreth, WT Jr, Weber, F, Lee, YC, Tsushima, Y, et al. (2009). Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 339, b3016.CrossRefGoogle ScholarPubMed
Naggara, ON, Lecler, A, Oppenheim, C, Meder, JF, Raymond, J. (2012). Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology, 263(3), 828–35.Google Scholar
O’Donnell, MJ, Chin, SL, Rangarajan, S, Xavier, D, Liu, L, Zhang, H, et al.; INTERSTROKE investigators. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet, 388(10046), 761–75. doi:10.1016/S0140-6736(16)30506-2. Epub 2016 Jul 16.Google ScholarPubMed
Owens, AP 3rd, Mackman, N. (2014). The antithrombotic effects of statins. Annu Rev Med, 65, 433–45.Google Scholar
Pandit, AK, Kumar, P, Kumar, A, Chakravarty, K, Misra, S, Prasad, K (2016). High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis. Acta Neurol Scand, 134(1), 22–8.Google Scholar
Poorthuis, MH, Klijn, CJ, Algra, A, Rinkel, GJ, Al-Shahi Salman, R. (2014). Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis. J Neurol Neurosurg Psychiatry, 85(12), 1319–23.CrossRefGoogle ScholarPubMed
PROGRESS Collaborative Group. (2001). Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet, 358(9287), 1033–41.Google Scholar
Providência, R, Grove, EL, Husted, S, Barra, S, Boveda, S, Morais, J. (2014). A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens. Thromb Res, 134(6), 1253–64.Google Scholar
Raaymakers, TW. (1999). Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic Resonance Angiography in Relatives of patients with Subarachnoid hemorrhage. Neurology, 53(5), 982–8.Google Scholar
Rapsomaniki, E, Timmis, A, George, J, Pujades-Rodriguez, M, Shah, AD, Denaxas, S, et al. (2014). Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet, 383(9932), 1899–911.Google Scholar
Ravindra, VM, de Havenon, A, Gooldy, TC, Scoville, J, Guan, J, Couldwell, WT, et al. (2018). Validation of the unruptured intracranial aneurysm treatment score: comparison with real-world cerebrovascular practice. J Neurosurg, 129(1), 100–06. doi:10.3171/2017.4.JNS17548.Google Scholar
Raymond, J, Darsaut, TE, Molyneux, AJ; TEAM Collaborative Group. (2011). A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials. Trials, 12(64). doi:10.1186/1745-6215-12-64.Google Scholar
Ridker, PM. (2018). Should aspirin be used for primary prevention in the post-statin era? N Engl J Med, 379(16), 1572–4.Google Scholar
Rodriguez-Torres, A, Murphy, M, Kourkoulis, C, Schwab, K, Ayres, AM, Moomaw, CJ, et al. (2018). Hypertension and intracerebral hemorrhage recurrence among white, black, and Hispanic individuals. Neurology, 91(1), e37e44.Google Scholar
Sacco, S, Marini, C, Toni, C, Olivieri, L, Carolei, A. (2009). Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke, 40(2), 394–9Google Scholar
Sabatine, MS, Giugliano, RP, Keech, AC, Honarpour, N, Wiviott, SD, Murphy, SA, et al.; FOURIER Steering Committee and Investigators. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med, 376(18), 1713–22.CrossRefGoogle ScholarPubMed
Saver, JL, Cushman, M. (2018). Striving for ideal cardiovascular and brain health: it is never too early or too late. JAMA, 320(7), 645–7.Google Scholar
Schurks, M, Glynn, RJ, Rist, PM, Tzourio, C, Kurth, T. (2010). Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ, 341, c5702.CrossRefGoogle ScholarPubMed
Shiue, I, Arima, H, Hankey, GJ, Anderson, C. (2012). Modifiable lifestyle behaviours account for most cases of subarachnoid haemorrhage: a population-based case-control study in Australasia. J Neurol Sci, 313(1–2), 92–4.Google Scholar
Spiegler, S, Rath, M, Paperlein, C, Felbor, U. (2018). Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol, 9(2), 60–9.Google Scholar
Steiner, T, Weitz, JI, Veltkamp, R. (2017). Anticoagulant-associated intracranial hemorrhage in the era of reversal agents. Stroke, 48(5), 1432–7.Google Scholar
Takao, H, Nojo, T, Ohtomo, K. (2008). Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis. Acad Radiol, 15(4), 462–71.Google Scholar
Thompson, BG, Brown, RD Jr., Amin-Hanjani, S, Broderick, JP, Cockroft, KM, Connolly, ES Jr, et al. (2015). Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 46(8), 2368–400.Google Scholar
Tulamo, R, Frösen, J, Hernesniemi, J, Niemelä, M. (2018). Inflammatory changes in the aneurysm wall: a review. J Neurointerv Surg, 10(Suppl 1), i58i67.CrossRefGoogle ScholarPubMed
Vergouwen, MD, de Haan, R, Vermeulen, M, Roos, YB. (2008). Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke, 39(2), 497502.Google Scholar
Villablanca, JP, Duckwiler, GR, Jahan, R, Tateshima, S, Martin, NA, Frazee, J, et al. (2013). Natural history of asymptomatic unruptured cerebral aneurysms evaluated at CT angiography: growth and rupture incidence and correlation with epidemiologic risk factors. Radiology, 269(1), 258–65.Google Scholar
Vlak, MH, Algra, A, Brandenburg, R, Rinkel, GJ. (2011). Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol, 10(7), 626–36.Google Scholar
Wang, X, Zhu, C, Leng, Y, Degnan, AJ, Lu, J. (2018). Intracranial aneurysm wall enhancement associated with aneurysm rupture: a systematic review and meta-analysis. Acad Radiol, 26(5), 664–73. doi:10.1016/j.acra.2018.05.005.Google Scholar
Wermer, MJ, Koffijberg, H, van der Schaaf, I. (2008). Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology, 70(22), 2053–62.Google Scholar
Wermer, MJ, van der Schaaf, IC, Algra, A, Rinkel, GJ. (2007). Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke, 38(4), 1404–10.Google Scholar
Whelton, PK, Carey, RM, Aronow, WS, Casey, DE Jr, Collins, KJ, Dennison Himmelfarb, C, et al. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71(6), e13e115.Google Scholar
Wiebers, DO, Whisnant, JP, Huston, J 3rd, Meissner, I, Brown, RD Jr, Piepgras, DG, et al. (2003). Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet, 362(9378), 103–10.Google Scholar
Zhang, Y, Tuomilehto, J, Jousilahti, P, Wang, Y, Antikainen, R, Hu, G. (2011). Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med, 171(20), 1811–18.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×